BP
BMY icon

Banyan Partners’s Bristol-Myers Squibb BMY Stock Holding History

Banyan Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$2.51M Sell
49,044
-2,338
-5% -$117K 0.21% 120
2014
Q2 		$2.49M Buy
51,382
+2,021
+4% +$99.6K 0.21% 127
2014
Q1 		$2.56M Sell
49,361
-5,159
-9% -$275K 0.22% 124
2013
Q4 		$2.9M Buy
54,520
+1,458
+3% +$74.3K 0.2% 103
2013
Q3 		$2.46M Buy
53,062
+14,978
+39% +$657K 0.22% 104
2013
Q2 		$1.7M Buy
+38,084
New +$1.65M 0.34% 83

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Banyan Partners's BMY Position: Q3 2014 in Review

Banyan Partners reduced its Bristol-Myers Squibb (BMY) stake by 4.6% in Q3 2014, selling an estimated $117K and leaving 49,044 shares worth $2.51M. The position accounts for 0.21% of the portfolio, ranked #120.

Banyan Partners first reported a position in BMY in Q2 2013 and has held it in 6 quarters since. The position peaked at $2.9M in Q4 2013. 1,301 funds tracked by Wall St. Rank hold BMY as of Q3 2014.

  • Banyan Partners held 49,044 shares of Bristol-Myers Squibb worth $2.51M as of Q3 2014.
  • Banyan Partners sold 2,338 Bristol-Myers Squibb shares in Q3 2014, an estimated $117K.
  • Bristol-Myers Squibb made up 0.21% of Banyan Partners's portfolio in Q3 2014, its #120 holding.
  • Banyan Partners first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 6 quarters since.
  • Banyan Partners's Bristol-Myers Squibb position peaked at $2.9M in Q4 2013.
  • 1,301 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2014.

Based on Banyan Partners's 13F filing for Q3 2014, filed 14 Nov 2014.